Facebook
Twitter
Telegram
Report an ErrorEiger BioPharmaceuticals Financial Statements 2011-2024 | EIGR
Annual Financial Statements Eiger BioPharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
3.11 M | 2.93 M | 170 M | 287 M | 279 M | 188 M | 79 M | 70.3 M | 26.7 M | 400 M | 145 M | - | - |
Shares |
1.48 M | 1.39 M | 33.9 M | 29.9 M | 22.8 M | 13.7 M | 8.73 M | 6.01 M | 1.59 M | 1.57 M | 1.18 M | - | - |
Historical Prices |
2.11 | 2.11 | 5.19 | 12.3 | 14.9 | 10.2 | 13.9 | 11.7 | 22.1 | 293 | - | - | - |
Net Income |
-75 M | -96.8 M | -33.9 M | -65.1 M | -70.3 M | -52.4 M | -42.4 M | -47.1 M | -44.4 M | -33.9 M | -20 M | -15.7 M | -6.99 M |
Revenue |
15.8 M | 13.5 M | 12.1 M | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
24 K | 1.84 M | 745 K | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-71.8 M | -92.7 M | -76.9 M | -62.1 M | -68.9 M | -51 M | -41.5 M | -46.1 M | -13 M | -1.52 M | -953 K | -15.9 M | - |
Interest Expense |
5.47 M | 4.13 M | 3.56 M | 3.59 M | 3.41 M | 2.33 M | 1.52 M | 690 K | 350 K | 741 K | 59 K | 108 K | - |
EBITDA |
-71.5 M | -92.4 M | -76.7 M | -61.5 M | -68.4 M | -51 M | -41.5 M | -46.1 M | -33.9 M | -32.9 M | -19.8 M | -15.7 M | -5.79 M |
Operating Expenses |
- | - | - | 62.1 M | 68.9 M | 51 M | 41.5 M | 46.1 M | 34.4 M | 33 M | - | - | - |
General and Administrative Expenses |
25.2 M | 29.1 M | 23.9 M | 20.6 M | 17.1 M | 14 M | 12 M | 13.1 M | 12.4 M | 10.3 M | 3.04 M | 2.63 M | 1.83 M |
All numbers in USD currency
Quarterly Income Statement Eiger BioPharmaceuticals
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
44.3 M | 44.3 M | 44.1 M | - | 44 M | 43.1 M | 35.3 M | 34.6 M | 33.9 M | 33.9 M | 33.9 M | 33.9 M | 29.9 M | 25.5 M | 24.5 M | 24.5 M | 24.4 M | 23.4 M | 19.2 M | 19.2 M | 14.3 M | 12 M | 10.5 M | 10.5 M | 8.37 M | 8.37 M | 8.36 M | 8.36 M | 7.62 M | 7.07 M | 936 K | 274 K | 195 K | 194 K | 194 K | 194 K | 20.8 M | 18.5 M | 11.9 M | 884 K | 884 K | 884 K | 884 K | - | - | - | - | - | - | - | - |
Net Income |
-18 M | -20.7 M | -22.8 M | - | -27.1 M | -21.9 M | -22.6 M | - | -22.2 M | -19.2 M | 29.2 M | - | -15.7 M | -15.3 M | -15.2 M | - | -18.6 M | -17.5 M | -17.2 M | - | -17.1 M | -9.92 M | -8.83 M | - | -9.17 M | -11.1 M | -11.2 M | - | -11.4 M | -13.2 M | -9.75 M | -4.75 M | -6.4 M | -16.5 M | -804 K | -11.3 M | -8.36 M | -6.99 M | -7.16 M | -6.18 M | -5.45 M | -4.89 M | -3.47 M | - | - | - | - | - | - | - | - |
Revenue |
3.21 M | 4.64 M | - | - | 4.02 M | 4.09 M | 2.67 M | - | 3.04 M | 2.1 M | 3.65 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
115 K | - | 118 K | - | 1.23 M | 151 K | 110 K | - | 318 K | 270 K | 53 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-16.9 M | -20 M | -22.3 M | - | -26.4 M | -20.1 M | -21.8 M | - | -21.9 M | -18.4 M | -15.8 M | - | -14.8 M | -14.6 M | -14.7 M | - | -18.3 M | -17.2 M | -16.9 M | - | -16.8 M | -9.61 M | -8.51 M | - | -8.87 M | -11.1 M | -11 M | - | -11.3 M | -13.2 M | -8.68 M | - | -2.87 M | -2.58 M | -804 K | - | -8.13 M | -7 M | -6.92 M | - | -5.52 M | -4.99 M | -3.47 M | - | - | - | - | - | - | - | - |
Interest Expense |
1.41 M | 1.34 M | 1.28 M | - | 1.09 M | 934 K | 886 K | - | 894 K | 880 K | 885 K | - | 906 K | 891 K | 884 K | - | 884 K | 869 K | 765 K | - | 681 K | 495 K | 398 K | - | 388 K | 378 K | 363 K | - | 685 K | 685 K | 685 K | - | 1.35 M | 445 K | 510 K | - | 271 K | 59 K | 59 K | - | 56 K | 43 K | -82 K | - | - | - | - | - | - | - | - |
EBITDA |
- | - | -22.2 M | - | -26.2 M | -20.1 M | -21.7 M | - | -21.6 M | -18.4 M | -15.7 M | - | -14.7 M | -14.6 M | -14.7 M | - | -18.3 M | -17.1 M | -16.9 M | - | -16.8 M | -9.59 M | -8.5 M | - | -8.84 M | -11.1 M | -11 M | - | -11.3 M | -13.2 M | -8.67 M | - | -2.86 M | -2.58 M | -802 K | - | -8.02 M | -6.94 M | -6.9 M | - | -5.47 M | -4.96 M | -3.46 M | - | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | 14.8 M | 14.6 M | 14.7 M | - | 18.3 M | 17.2 M | 16.9 M | - | 16.8 M | 9.61 M | 8.51 M | - | 8.87 M | 11.1 M | 11 M | - | 11.3 M | 13.2 M | 8.68 M | 4.76 M | 2.87 M | 2.58 M | 804 K | 11 M | 8.13 M | 7 M | 6.92 M | 5.98 M | 5.52 M | 4.99 M | 3.47 M | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
5.45 M | 5.53 M | 9.52 M | - | 6.96 M | 7.03 M | 6.81 M | - | 6.47 M | 5.89 M | 5.56 M | - | 5.03 M | 4.87 M | 5.24 M | - | 4.25 M | 4.22 M | 4.06 M | - | 3.64 M | 3.24 M | 2.99 M | - | 2.73 M | 2.95 M | 3.52 M | - | 3.26 M | 2.48 M | 3.83 M | - | 762 K | 577 K | 429 K | - | 2.82 M | 2.02 M | 1.71 M | - | 952 K | 775 K | 553 K | - | - | - | - | - | - | - | - |
All numbers in USD currency